Shanghai Hile Bio-Technology Co. Ltd. A | Ownership
Companies that own Shanghai Hile Bio-Technology Co. Ltd. A
China Life AMP Asset Management Co., Ltd.
12,030,000
1.87%
0
1.04%
07/26/2018
China Universal Asset Management Co., Ltd.
11,528,457
1.79%
-4,471,834
0.12%
03/31/2018
E Fund Management Co., Ltd.
6,764,541
1.05%
6,764,541
0.06%
12/31/2017
China Merchants Fund Management Co., Ltd.
539,698
0.08%
539,698
0.02%
12/31/2017
The Vanguard Group, Inc.
433,341
0.07%
0
0%
07/31/2018
HuaAn Fund Management Co., Ltd.
225,860
0.04%
-3,315,470
0%
12/31/2017
GF Fund Management Co., Ltd.
195,420
0.03%
19,000
0%
12/31/2017
Hui'an Fund Management Co. Ltd.
83,600
0.01%
83,600
0.02%
12/31/2017
China Fund Management Co., Ltd.
21,700
0%
21,700
0%
12/31/2017
China Southern Asset Management Co., Ltd.
7,700
0%
-400
0%
12/31/2017
| Address |
No. 6720 Jinhai Road
Shanghai Shanghai 201403
China
|
|
Employees
|
- |
| Website |
http://www.hile-bio.com |
| Updated |
07/08/2019 |
| Shanghai Hile Bio-Technology Co., Ltd. engages in the manufacture and sale of veterinary vaccine and inactivated vaccine. It specializes in pig, poultry, and pet vaccine products. It offers inactivated rabies vaccines, avian infectious bronchitis vaccine, swine fever vaccine, porcine transmissible gastroenteritis and porcine epidemic diarrhea bivalent inactivated vaccine, highly pathogenic blue ear pig disease vaccine, porcine reproductive and respiratory syndrome vaccine, and porcine circovirus type 2 inactivated vaccine. |
